The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
The hallmarks of Parkinson's disease
Open accessAbstract
Since the discovery of dopamine as a neurotransmitter in the 1950s, P arkinson's disease (PD) research has generated a rich and complex body of knowledge, revealing PD to be an age‐related multifactorial disease, influenced by both genetic and environmental factors. The tremendous complexity of the disease is increased by a nonlinear progression of the pathogenesis between molecular, cellular and organic systems. In this minireview, we explore the complexity of PD and propose a systems‐based approach, organizing the available information around cellular disease hallmarks. We encourage our peers to adopt this cell‐based view with the aim of improving communication in interdisciplinary research endeavors targeting the molecular events, modulatory cell‐to‐cell signaling pathways and emerging clinical phenotypes related to PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Tripartite synapses: astrocytes process and control synaptic information
Perea, G., Navarrete, M., & Araque, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.05.001 · Cited by 1,820
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Self-citationLewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722
Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling.
Lee, J., Giordano, S., & Zhang, J. (2012) · Biochemical Journal · doi:10.1042/bj20111451 · Cited by 1,438
The effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427
The Haber–Weiss reaction and mechanisms of toxicity
Kehrer, J. P. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00231-6 · Cited by 1,418
Genetics of Parkinson's Disease
Klein, C., & Westenberger, A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008888 · Cited by 1,358
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Mazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341
Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.485 · Cited by 1,324
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265
Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Canet-Avilés, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., & Cookson, M. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402959101 · Cited by 1,116
Abnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,063
Nemani, V. M., Lu, W., Berge, V., Nakamura, K., Onoa, B., Lee, M. K., Chaudhry, F. A., Nicoll, R. A., & Edwards, R. H. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.023 · Cited by 1,056
Metals, oxidative stress and neurodegenerative disorders
Jomova, K., Vondrakova, D., Lawson, M., & Valko, M. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0563-x · Cited by 1,052
Zhang, G., & Tandon, A. (2012) · Scientific Reports · doi:10.1038/srep00415 · Cited by 1,012
Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration
Sheng, Z.-H., & Cai, Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3156 · Cited by 903
Brain Imaging in Alzheimer Disease
Johnson, K. A., Fox, N. C., Sperling, R. A., & Klunk, W. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006213 · Cited by 875
Matsuda, W., Furuta, T., Nakamura, K. C., Hioki, H., Fujiyama, F., Arai, R., & Kaneko, T. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4029-08.2009 · Cited by 865
Hamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J., Yearout, D., Kay, D. M., Doheny, K. F., Paschall, J., Pugh, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.642 · Cited by 784
Neuron-glia metabolic coupling and plasticity
Magistretti, P. J. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2010.053157 · Cited by 747
Immune activation in brain aging and neurodegeneration: too much or too little?
Lucin, K. M., & Wyss-Coray, T. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.039 · Cited by 679
LRRK2 G2019S as a Cause of Parkinson's Disease in Ashkenazi Jews
Ozelius, L. J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., Hunt, A. L., Klein, C., Henick, B., Hailpern, S. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055509 · Cited by 665
Neuroinflammation in Parkinson's disease
Hirsch, E. C., Vyas, S., & Hunot, S. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70065-7 · Cited by 657
Exner, N., Lutz, A. K., Haass, C., & Winklhofer, K. F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.170 · Cited by 642
Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease
Postuma, R. B., Aarsland, D., Barone, P., Burn, D. J., Hawkes, C. H., Oertel, W., & Ziemssen, T. (2012) · Movement Disorders · doi:10.1002/mds.24996 · Cited by 612
Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling
Lo, S., Li, X., Henzl, M. T., Beamer, L. J., & Hannink, M. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601243 · Cited by 604
Fenton Chemistry: An Introduction
Wardman, P., & Candeias, L. P. (1996) · Radiation Research · doi:10.2307/3579270 · Cited by 587
Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
Sulzer, D. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.009 · Cited by 587
Shiba-Fukushima, K., Imai, Y., Yoshida, S., Ishihama, Y., Kanao, T., Sato, S., & Hattori, N. (2012) · Scientific Reports · doi:10.1038/srep01002 · Cited by 577
Mechanisms of cross‐talk between the ubiquitin‐proteasome and autophagy‐lysosome systems
Korolchuk, V. I., Menzies, F. M., & Rubinsztein, D. C. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.12.047 · Cited by 568
Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction
Tai, H.-C., & Schuman, E. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2499 · Cited by 532
Pan-Montojo, F., Anichtchik, O., Dening, Y., Knels, L., Pursche, S., Jung, R., Jackson, S., Gille, G., Spillantini, M. G., Reichmann, H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008762 · Cited by 524
Monogenic Mitochondrial Disorders
Koopman, W. J. H., Willems, P. H. G. M., & Smeitink, J. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1012478 · Cited by 522
Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin
Exner, N., Treske, B., Paquet, D., Holmström, K., Schiesling, C., Gispert, S., Carballo-Carbajal, I., Berg, D., Hoepken, H.-H., Gasser, T., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0719-07.2007 · Cited by 513
Self-citationGallagher, D. A., Lees, A. J., & Schrag, A. (2010) · Movement Disorders · doi:10.1002/mds.23394 · Cited by 509
Thiruchelvam, M., Richfield, E. K., Baggs, R. B., Tank, A. W., & Cory-Slechta, D. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09207.2000 · Cited by 471
Environmental Risk Factors and Parkinson's Disease: A Metaanalysis
Priyadarshi, A., Khuder, S. A., Schaub, E. A., & Priyadarshi, S. S. (2001) · Environmental Research · doi:10.1006/enrs.2001.4264 · Cited by 446
Living on the edge with too many mouths to feed: Why dopamine neurons die
Bolam, J. P., & Pissadaki, E. K. (2012) · Movement Disorders · doi:10.1002/mds.25135 · Cited by 436
Ageing, neurodegeneration and Parkinson's disease
Hindle, J. V. (2010) · Age and Ageing · doi:10.1093/ageing/afp223 · Cited by 430
Chu, Y., Dodiya, H., Aebischer, P., Olanow, C. W., & Kordower, J. H. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.023 · Cited by 421
Parkinson's Disease in a Chemist Working with 1-Methyl-4-Phenyl-L,2,5,6-Tetrahydropyridine
(1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090511 · Cited by 406
Reynolds, A. D., Stone, D. K., Hutter, J. A. L., Benner, E. J., Mosley, R. L., & Gendelman, H. E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901852 · Cited by 406
Pan-Montojo, F., Schwarz, M., Winkler, C., Arnhold, M., O'Sullivan, G. A., Pal, A., Said, J., Marsico, G., Verbavatz, J.-M., Rodrigo-Angulo, M., et al. (2012) · Scientific Reports · doi:10.1038/srep00898 · Cited by 405
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
The genetics of Parkinson's disease: Progress and therapeutic implications
Singleton, A. B., Farrer, M. J., & Bonifati, V. (2013) · Movement Disorders · doi:10.1002/mds.25249 · Cited by 354
Neuronal vulnerability, pathogenesis, and Parkinson's disease
Sulzer, D., & Surmeier, D. J. (2013) · Movement Disorders · doi:10.1002/mds.25095 · Cited by 315
Uversky, V. N. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0937-z · Cited by 312
Mitochondrial Biology and Parkinson's Disease
Perier, C., & Vila, M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009332 · Cited by 306
Parkinson's Disease: The Dual Hit Theory Revisited
Hawkes, C. H., Del Tredici, K., & Braak, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04365.x · Cited by 303
Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease
Ben‐Shachar, D., Riederer, P., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06358.x · Cited by 287
Neural Activity Controls the Synaptic Accumulation of α-Synuclein
Fortin, D. L., Nemani, V. M., Voglmaier, S. M., Anthony, M. D., Ryan, T. A., & Edwards, R. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2922-05.2005 · Cited by 271
Is Parkinson's disease a prion disorder?
Olanow, C. W., & Prusiner, S. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906759106 · Cited by 268
Nonmotor manifestations of Parkinson's disease
Simuni, T., & Sethi, K. (2009) · Annals of Neurology · doi:10.1002/ana.21472 · Cited by 235
Non-motor symptoms in Parkinson’s disease
Park, A., & Stacy, M. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5240-1 · Cited by 232
Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity
Gash, D. M., Rutland, K., Hudson, N. L., Sullivan, P. G., Bing, G., Cass, W. A., Pandya, J. D., Liu, M., Choi, D., Hunter, R. L., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21288 · Cited by 222
Hattingen, E., Magerkurth, J., Pilatus, U., Mozer, A., Seifried, C., Steinmetz, H., Zanella, F., & Hilker, R. (2009) · Brain · doi:10.1093/brain/awp293 · Cited by 222
Brain lactate kinetics: Modeling evidence for neuronal lactate uptake upon activation
Aubert, A., Costalat, R., Magistretti, P. J., & Pellerin, L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505427102 · Cited by 207
Zecca, L., Wilms, H., Geick, S., Claasen, J.-H., Brandenburg, L.-O., Holzknecht, C., Panizza, M. L., Zucca, F. A., Deuschl, G., Sievers, J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0361-7 · Cited by 205
Parkinson's disease: Evidence for environmental risk factors
Kieburtz, K., & Wunderle, K. B. (2013) · Movement Disorders · doi:10.1002/mds.25150 · Cited by 199
Gegg, M. E., Cooper, J. M., Schapira, A. H. V., & Taanman, J.-W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004756 · Cited by 198
Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line
Alvarez-Erviti, L., Couch, Y., Richardson, J., Cooper, J. M., & Wood, M. J. A. (2011) · Neuroscience Research · doi:10.1016/j.neures.2010.12.020 · Cited by 193
ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation
Schneider, S. A., Paisan‐Ruiz, C., Quinn, N. P., Lees, A. J., Houlden, H., Hardy, J., & Bhatia, K. P. (2010) · Movement Disorders · doi:10.1002/mds.22947 · Cited by 189
Solvent exposures and parkinson disease risk in twins
Goldman, S. M., Quinlan, P. J., Ross, G. W., Marras, C., Meng, C., Bhudhikanok, G. S., Comyns, K., Korell, M., Chade, A. R., Kasten, M., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22629 · Cited by 187
Regulation of astrocyte inflammatory responses by the Parkinson's disease‐associated gene DJ–1
Waak, J., Weber, S. S., Waldenmaier, A., Görner, K., Alunni‐Fabbroni, M., Schell, H., Vogt‐Weisenhorn, D., Pham, T., Reumers, V., Baekelandt, V., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-125153 · Cited by 186
Liang, C.-L., Wang, T. T., Luby-Phelps, K., & German, D. C. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.015 · Cited by 185
Tufekci, K. U., Civi Bayin, E., Genc, S., & Genc, K. (2011) · Parkinson's Disease · doi:10.4061/2011/314082 · Cited by 182
The Nrf2-Keap1-ARE Signaling Pathway: The Regulation and Dual Function of Nrf2 in Cancer
Zhang, D. D. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3301 · Cited by 178
Astrocyte-derived GDNF is a potent inhibitor of microglial activation
Rocha, S. M., Cristovão, A. C., Campos, F. L., Fonseca, C. P., & Baltazar, G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.04.014 · Cited by 178
Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease
Ling, H., Massey, L. A., Lees, A. J., Brown, P., & Day, B. L. (2012) · Brain · doi:10.1093/brain/aws038 · Cited by 176
Iron dysregulation in movement disorders
Dusek, P., Jankovic, J., & Le, W. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.054 · Cited by 169
Mitochondrial Dysfunction in Parkinson's Disease
Keane, P. C., Kurzawa, M., Blain, P. G., & Morris, C. M. (2011) · Parkinson's Disease · doi:10.4061/2011/716871 · Cited by 160
Introduction to Network Analysis in Systems Biology
Ma’ayan, A. (2011) · Science Signaling · doi:10.1126/scisignal.2001965 · Cited by 160
Wade, J. J., Mcdaid, L. J., Harkin, J., Crunelli, V., & Kelso, J. A. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029445 · Cited by 144
Dopamine-modified α-synuclein blocks chaperone-mediated autophagy
Martinez-Vicente, M., Talloczy, Z., Kaushik, S., Massey, A. C., Mazzulli, J., Mosharov, E. V., Hodara, R., Fredenburg, R., Wu, D.-C., Follenzi, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32806 · Cited by 144
Glial Cells as Players in Parkinsonism: The “Good,” the “Bad,” and the “Mysterious” Glia
Mena, M. A., & de Yébenes, J. G. (2008) · The Neuroscientist · doi:10.1177/1073858408322839 · Cited by 143
Oxidative insults induce DJ-1 upregulation and redistribution: Implications for neuroprotection
Lev, N., Ickowicz, D., Melamed, E., & Offen, D. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.01.007 · Cited by 134
Somatic mitochondrial DNA mutations in early parkinson and incidental lewy body disease
Lin, M. T. S., Cantuti‐Castelvetri, I., Zheng, K., Jackson, K. E., Tan, Y. B., Arzberger, T., Lees, A. J., Betensky, R. A., Beal, M. F., & Simon, D. K. (2012) · Annals of Neurology · doi:10.1002/ana.23568 · Cited by 132
Evaluation of LRRK2 G2019S penetrance
Goldwurm, S., Zini, M., Mariani, L., Tesei, S., Miceli, R., Sironi, F. M., Clementi, M., Bonifati, V., & Pezzoli, G. (2007) · Neurology · doi:10.1212/01.wnl.0000254483.19854.ef · Cited by 132
Neuronal regulation of immune responses in the central nervous system
Tian, L., Rauvala, H., & Gahmberg, C. G. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.11.002 · Cited by 130
Chan, C. S., Gertler, T. S., & Surmeier, D. J. (2010) · Movement Disorders · doi:10.1002/mds.22801 · Cited by 122
Orhan, H., Holland, B. J. V., Krab, B., Moeken, J., Vermeulen, N. P. E., Hollander, P., & Meerman, J. H. N. (2004) · Free Radical Research · doi:10.1080/10715760400013763 · Cited by 120
Marondedze, C., Turek, I., Parrott, B., Thomas, L. A., Janković, B. R., Lilley, K. S., & Gehring, C. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-1 · Cited by 120
Bellucci, A., Zaltieri, M., Navarria, L., Grigoletto, J., Missale, C., & Spano, P. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.014 · Cited by 115
Bioenergetic Consequences of PINK1 Mutations in Parkinson Disease
Abramov, A. Y., Gegg, M. E., Grünewald, A., Wood, N. W., Klein, C., & Schapira, A. H. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025622 · Cited by 103
Mizuno, Y., Suzuki, K., Sone, N., & Saitoh, T. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90705-7 · Cited by 94
Yanagida, T., Tsushima, J., Kitamura, Y., Yanagisawa, D., Takata, K., Shibaike, T., Yamamoto, A., Taniguchi, T., Yasui, H., Taira, T., et al. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.1.7985 · Cited by 93
Lysosomal dysfunction in Parkinson disease
Dehay, B., Martínez‐Vicente, M., Ramı́rez, A., Perier, C., Klein, C., Vila, M., & Bézard, E. (2012) · Autophagy · doi:10.4161/auto.21011 · Cited by 88
Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease
Riederer, P. F., Dirr, A., Goetz, M. E., Sofic, E., Jellinger, K. A., & Youdimt, M. B. H. (1992) · Annals of Neurology · doi:10.1002/ana.410320717 · Cited by 88
Parkinson’s disease mouse models in translational research
Antony, P. M. A., Diederich, N. J., & Balling, R. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9330-x · Cited by 84
Self-citationThe pathology roadmap in Parkinson disease
Surmeier, D. J., & Sulzer, D. (2013) · Prion · doi:10.4161/pri.23582 · Cited by 74
Crosiers, D., Theuns, J., Cras, P. P., & Broeckhoven, C. V. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.07.003 · Cited by 71
Lv, Z., Jiang, H. F., Xu, H., Song, N., & Xie, J. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0434-3 · Cited by 71
Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease
Schweitzer, K. J., Brüssel, T., Leitner, P., Krüger, R., Bauer, P., Woitalla, D., Tomiuk, J., Gasser, T., & Berg, D. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0369-7 · Cited by 71
Self-citationChelating Agents for Neurodegenerative Diseases
Ward, R. J., Dexter, D. T., & Crichton, R. R. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800609689 · Cited by 63
Cell metabolism affects selective vulnerability in PINK1-associated Parkinson's disease
Yao, Z., Gandhi, S., Burchell, V., Plun‐Favreau, H., Wood, N. W., & Abramov, A. Y. (2011) · Journal of Cell Science · doi:10.1242/jcs.088260 · Cited by 60
Keap1/Nrf2 system regulates neuronal survival as revealed through study of keap1 gene-knockout mice
Satoh, T., Harada, N., Hosoya, T., Tohyama, K., Yamamoto, M. P., & Itoh, K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.063 · Cited by 59
The control systems structures of energy metabolism
Cloutier, M., & Wellstead, P. E. (2009) · Journal of The Royal Society Interface · doi:10.1098/rsif.2009.0371 · Cited by 56
Genetics and iron in the systems biology of Parkinson’s disease and some related disorders
Funke, C., Schneider, S. A., Berg, D., & Kell, D. B. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.11.015 · Cited by 54
Light microscopy applications in systems biology: opportunities and challenges
Antony, P. M. A., Trefois, C., Stojanović, A., Baumuratov, A., & Kozak, K. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-24 · Cited by 53
Self-citationFrom Systems Biology to Systems Biomedicine
Antony, P. M. A., Balling, R., & Vlassis, N. A. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.11.009 · Cited by 40
Self-citationAn energy systems approach to Parkinson's disease
Wellstead, P. E., & Cloutier, M. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.107 · Cited by 34
DNA Topoisomerase II Modulates Insulator Function in Drosophila
Ramos, E., Torre, E. A., Bushey, A. M., Gurudatta, B. V., & Corces, V. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016562 · Cited by 29
Casey, G. J., Jolley, D., Phuc, T. Q., Tinh, T. T., Tho, D. H., Montresor, A., & Biggs, B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015691 · Cited by 27
Song, M., Paul, S., Lim, H., Dayem, A. A., & Cho, S. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-0205-9 · Cited by 23
Cited by
Update of the MDS research criteria for prodromal Parkinson's disease
Heinzel, S., Berg, D., Gasser, T., Chen, H., Yao, C., Postuma, R. B., & the MDS Task Force on the Definition of Parkinson's Disease (2019) · Movement Disorders · doi:10.1002/mds.27802 · Cited by 768
Blevins, H. M., Xu, Y., Biby, S., & Zhang, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.879021 · Cited by 587
Prodromal Parkinson disease subtypes — key to understanding heterogeneity
Berg, D., Borghammer, P., Fereshtehnejad, S.-M., Heinzel, S., Horsager, J., Schaeffer, E., & Postuma, R. B. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00486-9 · Cited by 409
Białkowska, K., Komorowski, P., Bryszewska, M., & Miłowska, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176225 · Cited by 382
Centeno, E. G. Z., Cimarosti, H., & Bithell, A. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0258-4 · Cited by 268
Metadata
- Authors
- Antony, P. M. A., Diederich, N. J., Krüger, R., & Balling, R.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2013-06-10
- Volume
- 280
- Issue
- 23
- Pages
- 5981-5993
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W1979883589
- Cited by
- 300
- References
- 124
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.